Researchers presenting preliminary data from a clinical trial aimed at discovering a cure for sickle cell disease reveal positive results among its first patients.
Jun 9, 2023
0
5
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles. There is no cure, and current treatments focus on reducing ...
Jun 1, 2023
0
116
An estimated 2.8 million people around the world have multiple sclerosis (MS), an autoimmune disease in which the immune system damages the brain and spinal cord.
May 22, 2023
0
6
Peresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patients with rheumatoid arthritis, according ...
May 18, 2023
0
18
One of the most important advances in palliative care in oncology over the past 15 years has been the recognition that palliative care specialists can improve cancer patients' outcomes well before their end of life.
May 10, 2023
0
4
Colorectal cancer is the fourth most common and second deadliest cancer. How colorectal cancer develops is not well understood, but a team led by researchers at Baylor College of Medicine reports in the Journal of Experimental ...
May 10, 2023
0
7
When the heart gets out of rhythm, characteristic processes occur in the heart muscle cells. Among other things, the currents of electrically charged particles (ions) change. In chronic atrial fibrillation, one of these currents ...
Apr 25, 2023
0
83
It's a controversial notion, but couples undergoing fertility treatments may soon be able to select the sex of their baby—with an 80% chance of success, doctors say.
Mar 22, 2023
0
24
Rice University bioengineer Omid Veiseh and collaborators have found that lipid deposition on the surfaces of implants can play a mediating role between the body and implants, with some lipids acting as peacekeepers while ...
Mar 14, 2023
0
39
A one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) therapy by the University of Sydney did not lead to lower rates of skin cancer in organ transplant recipients. The result is in striking contrast to a ...
